A share price of Bright Minds Biosciences Inc [DRUG] is currently trading at $90.01, down -6.22%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The DRUG shares have gain 15.34% over the last week, with a monthly amount glided 10.96%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Bright Minds Biosciences Inc [NASDAQ: DRUG] stock has seen the most recent analyst activity on September 08, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $72. On May 07, 2025, Chardan Capital Markets initiated with a Buy rating and assigned a price target of $80 on the stock. Piper Sandler started tracking the stock assigning an Overweight rating and suggested a price target of $93 on January 23, 2025. H.C. Wainwright initiated its recommendation with a Buy and recommended $85 as its price target on January 10, 2025. In a note dated November 26, 2024, Robert W. Baird initiated an Outperform rating and provided a target price of $75 on this stock.
Bright Minds Biosciences Inc experienced fluctuations in its stock price throughout the past year between $23.17 and $123.75. Currently, Wall Street analysts expect the stock to reach $144.5 within the next 12 months. Bright Minds Biosciences Inc [NASDAQ: DRUG] shares were valued at $90.01 at the most recent close of the market. An investor can expect a potential return of 60.54% based on the average DRUG price forecast.
Analyzing the DRUG fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.2 and Total Capital is -0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 85.65 points at the first support level, and at 81.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 94.99, and for the 2nd resistance point, it is at 99.98.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Bright Minds Biosciences Inc [NASDAQ:DRUG] is 36.10. Also, the Quick Ratio is 36.10, while the Cash Ratio stands at 35.5.
